Legal & General Group Plc - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 189 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$573,405
-10.6%
45,079
-1.0%
0.00%
Q2 2023$641,133
+66.6%
45,535
+82.8%
0.00%
Q1 2023$384,937
+24.3%
24,915
+31.9%
0.00%
Q4 2022$309,624
-7.8%
18,891
+4.2%
0.00%
Q3 2022$336,000
+2.8%
18,137
-27.1%
0.00%
Q2 2022$327,000
+115.1%
24,882
+51.8%
0.00%
Q1 2022$152,000
-53.9%
16,395
-51.4%
0.00%
Q4 2021$330,000
-68.1%
33,723
+10.7%
0.00%
Q3 2021$1,035,000
+25.5%
30,456
+35.1%
0.00%
Q2 2021$825,000
-17.6%
22,537
+1.0%
0.00%
Q1 2021$1,001,000
-21.6%
22,310
-0.2%
0.00%
Q4 2020$1,276,000
+11.1%
22,360
-0.2%
0.00%
-100.0%
Q3 2020$1,149,000
-20.0%
22,397
-6.8%
0.00%0.0%
Q2 2020$1,436,000
+191.9%
24,042
+101.2%
0.00%
Q1 2020$492,000
-79.4%
11,948
-68.8%
0.00%
-100.0%
Q4 2019$2,385,000
+1438.7%
38,320
+741.5%
0.00%
Q3 2019$155,000
+150.0%
4,554
+63.6%
0.00%
Q2 2019$62,000
+59.0%
2,784
+69.0%
0.00%
Q1 2019$39,000
+11.4%
1,6470.0%0.00%
Q4 2018$35,000
-45.3%
1,6470.0%0.00%
Q3 2018$64,000
+52.4%
1,647
+55.4%
0.00%
Q2 2018$42,000
+44.8%
1,060
-26.0%
0.00%
Q1 2018$29,000
-12.1%
1,4320.0%0.00%
Q4 2017$33,0001,4320.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$15,385,74319.76%
Redmile Group, LLC 4,475,384$56,926,8842.71%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,897,606$87,737,5481.93%
Parkman Healthcare Partners LLC 597,403$7,598,9661.39%
Ghost Tree Capital, LLC 325,000$4,134,0001.36%
BRAIDWELL LP 3,336,221$42,436,7311.34%
AlphaCentric Advisors LLC 132,000$1,679,0400.95%
ARMISTICE CAPITAL, LLC 4,612,000$58,664,6400.90%
Sunesis Advisors, LLC 96,299$1,224,9230.87%
EcoR1 Capital, LLC 993,000$12,630,9600.43%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders